Skip to main content
Fig. 4 | Alzheimer's Research & Therapy

Fig. 4

From: Plasma amyloid assay as a pre-screening tool for amyloid positron emission tomography imaging in early stage Alzheimer’s disease

Fig. 4

Comparison of the detection accuracy for amyloid PET+ subjects with clinically suspected mild stage AD based on genetic and plasma biomarkers. Abbreviations: Aβ, Amyloid β; AD, Alzheimer’s disease; CDR, Clinical Dementia Rating Scale; MMSE, Mini-Mental State Examination; PET+, amyloid positron emission tomography positivity; PET−, amyloid positron emission tomography negativity

Back to article page

Alzheimer's Research & Therapy

ISSN: 1758-9193